Infectious Diseases (except HIV/AIDS)

  1. Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS

    1. Hooman H. Rashidi
    2. John Pepper
    3. Taylor Howard
    4. Karina Klein
    5. Larissa May
    6. Samer Albahra
    7. Brett Phinney
    8. Michelle R. Salemi
    9. Nam K. Tran

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SurvMaximin: Robust federated approach to transporting survival risk prediction models

    1. Xuan Wang
    2. Harrison G. Zhang
    3. Xin Xiong
    4. Chuan Hong
    5. Griffin M. Weber
    6. Gabriel A. Brat
    7. Clara-Lea Bonzel
    8. Yuan Luo
    9. Rui Duan
    10. Nathan P. Palmer
    11. Meghan R. Hutch
    12. Alba Gutiérrez-Sacristán
    13. Riccardo Bellazzi
    14. Luca Chiovato
    15. Kelly Cho
    16. Arianna Dagliati
    17. Hossein Estiri
    18. Noelia García-Barrio
    19. Romain Griffier
    20. David A. Hanauer
    21. Yuk-Lam Ho
    22. John H. Holmes
    23. Mark S. Keller
    24. Jeffrey G. Klann MEng
    25. Sehi L'Yi
    26. Sara Lozano-Zahonero
    27. Sarah E. Maidlow
    28. Adeline Makoudjou
    29. Alberto Malovini
    30. Bertrand Moal
    31. Jason H. Moore
    32. Michele Morris
    33. Danielle L. Mowery
    34. Shawn N Murphy
    35. Antoine Neuraz
    36. Kee Yuan Ngiam
    37. Gilbert S. Omenn
    38. Lav P. Patel
    39. Miguel Pedrera-Jiménez
    40. Andrea Prunotto
    41. Malarkodi Jebathilagam Samayamuthu
    42. Fernando J Sanz Vidorreta
    43. Emily R. Schriver
    44. Petra Schubert
    45. Pablo Serrano-Balazote
    46. Andrew M. South
    47. Amelia L.M. Tan
    48. Byorn W.L. Tan
    49. Valentina Tibollo
    50. Patric Tippmann
    51. Shyam Visweswaran
    52. Zongqi Xia
    53. William Yuan
    54. Daniela Zöller
    55. Isaac S. Kohane
    56. Paul Avillach
    57. Zijian Guo
    58. Tianxi Cai

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

    1. Adeola Fowotade
    2. Folasade Bamidele
    3. Boluwatife Egbetola
    4. Adeniyi F. Fagbamigbe
    5. Babatunde A. Adeagbo
    6. Bolanle O. Adefuye
    7. Ajibola Olagunoye
    8. Temitope O. Ojo
    9. Akindele O. Adebiyi
    10. Omobolanle I. Olagunju
    11. Olabode T. Ladipo
    12. Abdulafeez Akinloye
    13. Adedeji Onayade
    14. Oluseye O. Bolaji
    15. Steve Rannard
    16. Christian Happi
    17. Andrew Owen
    18. Adeniyi Olagunju

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes

    1. Colin Pawlowski
    2. Eli Silvert
    3. John C O'Horo
    4. Patrick J Lenehan
    5. Doug Challener
    6. Esteban Gnass
    7. Karthik Murugadoss
    8. Jason Ross
    9. Leigh Speicher
    10. Holly Geyer
    11. A J Venkatakrishnan
    12. Andrew D Badley
    13. Venky Soundararajan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and Omicron

    1. Zachary A. Weishampel
    2. Janean Young
    3. Mark Fischl
    4. Robert J. Fischer
    5. Irene Owusu Donkor
    6. Jade C. Riopelle
    7. Jonathan E. Schulz
    8. Julia R. Port
    9. Taylor A. Saturday
    10. Neeltje van Doremalen
    11. Jody D. Berry
    12. Vincent J. Munster
    13. Claude Kwe Yinda

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Transparency and reporting characteristics of COVID-19 randomized controlled trials

    1. Philipp Kapp
    2. Laura Esmail
    3. Lina Ghosn
    4. Philippe Ravaud
    5. Isabelle Boutron

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report

    1. Natalie Bruiners
    2. Valentina Guerrini
    3. Rahul Ukey
    4. Ryan J. Dikdan
    5. Jason H. Yang
    6. Pankaj Kumar Mishra
    7. Alberta Onyuka
    8. Deborah Handler
    9. Joshua Vieth
    10. Mary Carayannopoulos
    11. Shuang Guo
    12. Maressa Pollen
    13. Abraham Pinter
    14. Sanjay Tyagi
    15. Daniel Feingold
    16. Claire Philipp
    17. Steven K. Libutti
    18. Maria Laura Gennaro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome

    1. Matthew L Robinson
    2. C Paul Morris
    3. Joshua F Betz
    4. Yifan Zhang
    5. Robert Bollinger
    6. Natalie Wang
    7. David R Thiemann
    8. Amary Fall
    9. Raghda E Eldesouki
    10. Julie M Norton
    11. David C Gaston
    12. Michael Forman
    13. Chun Huai Luo
    14. Scott L Zeger
    15. Amita Gupta
    16. Brian T Garibaldi
    17. Heba H Mostafa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. MACHINE LEARNING IMPACT ASSESSMENT OF CLIMATE FACTORS ON DAILY COVID-19 CASES

    1. Stephen Afrifa
    2. Essien Felix Ato
    3. Peter Appiahene
    4. Isaac Wiafe
    5. Rose-Mary Owusuaa Mensah Gyening
    6. Michael Opoku

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Concordance of B‐ and T‐cell responses to SARS‐CoV‐2 infection, irrespective of symptoms suggestive of COVID‐19

    1. Marc F. Österdahl
    2. Eleni Christakou
    3. Deborah Hart
    4. Ffion Harris
    5. Yasaman Shahrabi
    6. Emily Pollock
    7. Muntaha Wadud
    8. Tim D. Spector
    9. Matthew A. Brown
    10. Jeffrey Seow
    11. Michael H. Malim
    12. Claire J. Steves
    13. Katie J. Doores
    14. Emma L. Duncan
    15. Timothy Tree

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 208 of 716 Next